raloxifene hydrochloride has been researched along with Chronic Kidney Failure in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Gong, W; Lu, LL; Ma, HY; Zhang, AH | 1 |
| Hirai, K; Inoue, T; Kanehara, H; Nagatoya, K; Nishimoto, K; Okada, S; Shibahara, N; Takahashi, T; Ueda, H; Ueno, N; Yasuda, H | 1 |
| Eriguchi, R; Miura, S; Sato, Y; Umakoshi, J | 1 |
| Genc, H; Kaya, H; Ozbasar, D; Ozkaya, O; Sezik, M; Toros, U; Uzun, H | 1 |
| Alonzo, E; Bajares-Lilue, M; Bellorin-Font, E; Capriles, F; Carlini, R; Hernández, E; Martinis, R; Valera, R; Weisinger, JR | 1 |
| Blackwell, T; Cummings, SR; Ensrud, KE; Ishani, A; Jamal, SA | 1 |
1 review(s) available for raloxifene hydrochloride and Chronic Kidney Failure
| Article | Year |
|---|---|
Raloxifene in the Treatment of Osteoporosis in Postmenopausal Women with End-Stage Renal Disease: A Systematic Review and Meta-Analysis.
Topics: Aged; Female; Humans; Kidney Failure, Chronic; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Raloxifene Hydrochloride | 2021 |
4 trial(s) available for raloxifene hydrochloride and Chronic Kidney Failure
| Article | Year |
|---|---|
Raloxifene ameliorates progressive bone loss in postmenopausal dialysis patients with controlled parathyroid hormone levels.
Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Disease Progression; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Immunoradiometric Assay; Kidney Failure, Chronic; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Raloxifene Hydrochloride; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2009 |
Raloxifene decreases serum malondialdehyde and nitric oxide levels in postmenopausal women with end-stage renal disease under chronic hemodialysis therapy.
Topics: Aged; Antioxidants; Female; Humans; Kidney Failure, Chronic; Lipase; Lipoproteins, HDL; Lipoproteins, LDL; Malondialdehyde; Middle Aged; Nitric Oxide; Oxidative Stress; Postmenopause; Raloxifene Hydrochloride; Renal Dialysis; Selective Estrogen Receptor Modulators | 2010 |
Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis.
Topics: Aged; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Estrogen Antagonists; Female; Humans; Kidney Failure, Chronic; Lipids; Middle Aged; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Renal Dialysis | 2003 |
The effect of raloxifene treatment in postmenopausal women with CKD.
Topics: Adult; Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Female; Humans; Kidney Failure, Chronic; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Spinal Fractures | 2008 |
1 other study(ies) available for raloxifene hydrochloride and Chronic Kidney Failure
| Article | Year |
|---|---|
Effects of raloxifene on bone metabolism in postmenopausal women on chronic hemodialysis.
Topics: Acid Phosphatase; Aged; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Density Conservation Agents; Bone Resorption; Female; Humans; Isoenzymes; Kidney Failure, Chronic; Middle Aged; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Parathyroid Hormone; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Renal Dialysis; Tartrate-Resistant Acid Phosphatase | 2015 |